611 W. Union Street
Benson, AZ 85602
(520) 586-0800

member support line
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line


powered by centersite dot net
Medical Disorders
Basic InformationLookupsLatest News
Global Warming Could Make Survival in Tropics Impossible: StudyObesity a Big Risk Factor for Severe COVID-19, Study ConfirmsWildfire Smoke Is Especially Toxic to Lungs, Study ShowsNo Sense of Smell After COVID? Therapies Can Help Bring It BackPandemic Stress Has More Americans Grinding Their TeethHad Sinus Surgery? Better Skip Nasal Swab COVID TestEven 1 Dose of Pfizer, AstraZeneca COVID Vaccines Offer Good Protection for People Over 80Could a Drug Prevent Type 1 Diabetes in Those at Risk?CDC Issues New Guidelines for Vaccinated AmericansAHA News: COVID-19 Mental Health Crisis Is Hitting Young AdultsHow Moving the Homeless to Hotels During the Pandemic Helps EveryoneA Vaccine Against UTIs? New Mouse Study Brings Shot CloserOpioid Use (and Overuse) for Knee Arthritis Takes Big Financial TollFormaldehyde in Hair Straighteners Prompts FDA WarningIt's Too Soon to Lift COVID Restrictions: FauciWith 3 COVID Vaccines Approved, Is There a 'Best' Shot?U.S. Hispanics at High Stroke Risk and Many Go Untreated: ReportCOVID Leaves Most Pro Athletes With No Lasting Heart Damage: StudyAmerican Indians Face the Highest Odds for StrokePerils of the Pandemic: Scooters, Cleansers and Button BatteriesModerna COVID Vaccine Can Sometimes Trigger Delayed Skin ReactionsMore Data Suggests New Coronavirus Variants Weaken Vaccines, TreatmentsAdd Sleep Woes to Long-Term Effects of ConcussionsCOVID Death Rates 10 Times Higher in Countries Where Most Are Overweight: ReportCould Taking a Swing at Golf Help Parkinson's Patients?Scientists Discover Why Blood Type May Matter for COVID InfectionNew Coronavirus Variant Out of Brazil Now in 5 U.S. StatesScientists Gain Insight Into Genetics of GlaucomaPatients With Sickle Cell Disease Often Overlooked for Life-Saving Kidney TransplantsDoes an Arthritis Drug Help Patients Battling Severe COVID? It Depends on the StudyNIH Halts Trial of Convalescent Plasma for Mild COVID-19COVID Vaccines for All American Adults by the End of May: BidenWhat You Need to Know About the New J&J COVID VaccineHow Climate Change Could Put More MS Patients in DangerFace Masks Won't Impede Your Breathing, Study ConfirmsSports Position Doesn't Affect Risk of Concussion-Linked CTE IllnessStrep Throat Doesn't Worsen Tourette But May Affect ADHD: StudyFauci Says U.S. Will Stay With Two Doses of Pfizer, Moderna VaccinesAHA News: Finally Getting Around to That Annual Physical? Here's What You Might FindStem Cell Injections Show Early Promise Against Spinal Cord InjuriesStudy Debunks Notion That Statin Meds Trigger Muscle AchesMore Than 87,000 Scientific Papers Already Published on COVID-19Underarm Lump After COVID Shot Is Likely Lymph Swelling, Not Breast Cancer, Experts SayVaccinating Oldest First for COVID Saves the Most Lives: StudyIf Protections Expire, COVID Patients Could Soon Face Big Medical BillsSharp Drop Seen in COVID Testing As New Cases PlateauFDA Approves Third COVID VaccineSpring Allergies Are Near, Here's What Works to Fight ThemRheumatoid Arthritis Meds May Help Fight Severe COVID-19Hair Salon Talk Can Spread COVID, But Face Shields Cut the Danger
Questions and AnswersLinksBook Reviews
Related Topics

Men's Health
Women's Health

New Rabies Prevention Treatment Also Works in Kids: Study

HealthDay News
by Robert Preidt
Updated: Feb 16th 2021

new article illustration

TUESDAY, Feb. 16, 2021 (HealthDay News) -- Getting bitten by a dog or wild animal is frightening, especially for kids, but a new study may help relieve some of the worry about catching rabies.

The rabies prevention treatment KEDRAB is safe and effective for patients 17 and younger, a groundbreaking pediatric clinical trial has shown.

The trial included 30 kids with suspected or confirmed rabies exposure who were treated with KEDRAB (Rabies Immune Globulin [Human]) and followed for 84 days.

KEDRAB was put into and around detectable wounds and/or given intramuscularly along with the first of a four-dose series of rabies vaccine.

None of the patients developed an active rabies infection, and there were no deaths or serious side effects, the researchers reported.

Seven in 10 did have mild side effects, according to findings published Feb. 10 in the journal Human Vaccines & Immunotherapeutics.

This is the first human rabies immunoglobulin shown to be safe and effective in children when used immediately as part of post-exposure disease prevention, the study authors said.

Other steps include thorough washing of the wound and four doses of rabies vaccine over two weeks.

Results of the trial — the first among kids — have been submitted to the U.S. Food and Drug Administration for review. KEDRAB is not licensed outside the United States.

"Despite the large proportion of pediatric cases, limited safety and efficacy data had previously existed for use in pediatric patients," said study senior author Dr. James Linakis. He's a professor of emergency medicine and pediatrics at Brown University's Warren Alpert Medical School in Providence, R.I.

Dr. Nicholas Hobart-Porter, a pediatric emergency doctor at the Arkansas Children's Hospital in Little Rock, led the trial.

He said the findings confirm that KEDRAB addresses an unmet need in children who may have been exposed to rabies.

"Evidence from this … trial gives health care providers confidence when preventing this deadly condition in countless numbers of young patients across the U.S.," Hobart-Porter said in a journal news release.

Once symptoms appear, rabies is nearly always fatal. Rabies causes 59,000 deaths a year in more than 150 countries, according to the World Health Organization (WHO).

The WHO said that 95% of rabies cases occur in Africa and Asia. About 40% of the global cases are in children younger than 15 years. Most cases are caused by dog bites.

In the United States, someone is treated for possible rabies exposure every 10 minutes, but the disease itself is very rare among Americans, with an average of two deaths per year, the study authors said.

More information

The World Health Organization has more on rabies.

SOURCE: Human Vaccines & Immunotherapeutics, news release, Feb. 10, 2021